FridaySep 08, 2023 12:22 pm

TinyGemsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) ‘Strategically Important’ Patent Grants Protection in One of World’s Leading Oral Nicotine Markets

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, recently celebrated the receipt of U.S. patent #11,700,875, titled “Compositions and Methods For Sublingual Delivery of Nicotine.” The patent covers various forms and sources of nicotine, including nicotine benzoate, nicotine polacrilex, nicotine citrate, nicotine detartrate, and many others, for use in sublingual delivery formats like oral pouches. “The new U.S. patent is remarkable and ‘strategically important’ in many ways. First, it is the company’s 35th overall granted patent worldwide and the 13th granted in the United States. Second, a total of 30 claims were awarded within this patent,…

Continue Reading

FridaySep 08, 2023 11:25 am

TinyGemsBreaks – GEMXX Corp. (GEMZ) Eyes Promising Start to Expected ‘Highly Lucrative’ First Year of Gold Mining

GEMXX (OTC: GEMZ), a mine-to-market global jewelry producer, is ramping up its capacity for gold ore processing at one of its Canadian assets, enthusiastic over the better-than-expected amount of ore produced from stockpiled surface material. “GEMXX’s Snow Creek Mine property in British Columbia completed site preparation for gold processing last year and mobilized equipment in May to begin bringing the property into full production. GEMXX reported the first production of gold from the site on Aug. 15 as ore collected from a 4,500-cubic-yard sample during construction of the facility was ‘cleaned out.’ The operation yielded 38.73 ounces of gold, amounting…

Continue Reading

FridaySep 08, 2023 10:38 am

TinyGemsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Deploys K5 ASRs for New Client, 2nd-Year Contract Renewal

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”) and blue light emergency communication systems, has announced another new deployment and contract renewal for K5 ASRs. The announcement reads, “Knightscope’s commitment to making children safe extends beyond the classroom and into extracurricular and recreational activities. With over 3.5 billion followers worldwide, soccer is the number one sport on planet Earth, and Knightscope has begun protecting a new generation of players and fans in New York. A soccer academy and sports complex in Long Island now has a K5 ASR securing its entrance against trespassers and patrolling its parking…

Continue Reading

ThursdaySep 07, 2023 4:56 pm

TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces 200-Patient Enrollment Milestone in Potentially Pivotal Berubicin Study

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced enrollment of 200 of the expected 243 patients in the company’s ongoing potentially pivotal study evaluating Berubicin for the treatment of recurrent Glioblastoma Multiforme (“GBM”), an aggressive and incurable form of brain cancer. “As we have noted previously, patient volunteers and their treating clinicians are the backbone of our Berubicin development program. We are deeply sensitive to the fact that these brave patients are facing the battle of their lives and we…

Continue Reading

ThursdaySep 07, 2023 4:46 pm

TinyGemsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) to Present at H.C. Wainwright 25th Annual Global Investment Conference

InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development, manufacturing, and commercialization of rare cannabinoids and cannabinoid analogs, today announced its participation in the H.C. Wainwright Global Investment Conference, which is taking place Sept. 11-13, 2023, in New York City. The on-demand presentation by InMed’s CEO Eric A. Adams will be available beginning at 7 a.m. ET on Sept. 11 via webcast, and a recording will also be accessible on InMed’s Investor Relations website for a period of 90 days. In addition, InMed’s management team will be available for one-on-one meetings with registered investors during the conference. Interested…

Continue Reading

ThursdaySep 07, 2023 4:28 pm

TinyGemsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Receives Delisting Notification from NASDAQ, Files an Appeal

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has received a letter from the Listing Qualifications Department of the NASDAQ Stock Market. The letter notes that MULN did not meet the deadline to regain compliance with NASDAQ listing requirements; the deadline was Sept. 5, 2023. According to the notice, the company failed to maintain a minimum bid price of $1. In response to the notice, Mullen Automotive has filed an appeal, requesting a hearing before the NASDAQ Listing Qualifications Panel. The company intends to request an extension of time and the opportunity to present its plan to regain…

Continue Reading

ThursdaySep 07, 2023 4:03 pm

TinyGemsBreaks – Knightscope, Inc. (NASDAQ: KSCP) K5 ASRs Deployed to Oregon Hospital and Texas-Based Industrial Facility

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”) and blue light emergency communication systems, has announced a new deployment and another contract renewal, which both utilize the company’s K5 ASR. The announcement reads, “An Oregon healthcare organization with more than 70 primary care, specialty and urgent care clinics; a hospital; a children’s hospital; and a 24-hour mental and behavioral health services center, deployed its first K5 ASR at its hospital, a use case that represents one of Knightscope’s fastest growing market segments. When following Knightscope’s recommendations, ASRs can help healthcare clients meet or exceed the Joint Commission…

Continue Reading

ThursdaySep 07, 2023 2:54 pm

TinyGemsBreaks – Genprex Inc. (NASDAQ: GNPX) to Present at Upcoming H.C. Wainwright Conference

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing treatments for patients with cancer and diabetes, today announced that its CFO Ryan Confer will be providing an overview of the company's pioneering gene therapies for cancer and diabetes at the upcoming H.C. Wainwright 25th Annual Global Investment Conference. Confer’s presentation is scheduled to begin at 3:00 p.m. ET on Wednesday, Sep. 13, 2023. Interested parties should visit https://ibn.fm/vvilS to register and access the presentation. A recording will be available for replay on Genprex’s website for a period of time. In addition, as detailed in the announcement, Confer…

Continue Reading

WednesdaySep 06, 2023 3:29 pm

TinyGemsBreaks – Why RVL Pharmaceuticals plc (NASDAQ: RVLP) Is ‘One to Watch’

RVL Pharmaceuticals (NASDAQ: RVLP) is a specialty pharmaceutical company focusing on the commercialization of UPNEEQ(R) (oxymetazoline hydrochloride ophthalmic solution), 0.1%, available by prescription for the treatment of acquired blepharoptosis (low-lying eyelid(s)) in adults. “UPNEEQ(R) (‘RVL-1201’) is the first non-surgical treatment option approved by the U.S. Food and Drug Administration (‘FDA’) for acquired blepharoptosis. The company received FDA approval in July 2020 and launched UPNEEQ(R) in September 2020 to a limited number of eye care professionals, with commercial operations expanded in 2021 among ophthalmology, optometry and oculoplastic specialties,” a recent article reads. “In February 2022, UPNEEQ(R) was launched into the medical…

Continue Reading

WednesdaySep 06, 2023 10:30 am

TinyGemsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Announces Record Capacity Levels for Fr8Fleet

Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”) is a technology company offering its custom-developed Fr8App, an industry-leading freight-matching platform that offers a B2B cloud-based solution for cross-border and domestic shipping within the USMCA region. The company reported a record number of active carriers in its Fr8Fleet brand at end of August 2023, an increase of 60.8% versus year-ago levels and an increase of 55.7% versus YTD average capacity levels through August. “Following a challenging first quarter of the year, we had to cycle through some underperforming carriers during Q1-23 – which hurt our numbers for the first quarter, but we believe we…

Continue Reading

Contact us: (512) 354-7000